Submissions

The HealthInvestor Asia Awards celebrate excellence and recognise innovation in the healthcare sector. In each of the categories an independent panel of high profile judges will be looking for organisations and individuals that have made an outstanding contribution to healthcare in 2018.

To enter your business or team, or to nominate someone else, simply complete the entry form below and explain in no more than 2,000 words why they should win. The closing date for entries will be Friday 18 January 2019.

How to enter

The judges will only consider applications that include the following points.

  • A short overview of the business, what it does and how it fits into the sector.
  • Details of relevant activities during 2018 including, where applicable, a full list of healthcare deals and projects or case studies on which the organisation has worked on.
  • Relevant financial detail.
  • How your company has exceeded the market and delivered a measurable contribution either through the complexity, scale or volume of your work over the past 12 months.

All points need to be covered in the 2,000 word limit.

Submissions must include a fully completed entry form (below) and be no more than 2,000 words.

The judging panel reserves the right to move entries from one category to another if they feel it is more appropriate. Please ensure that all information in submissions is accurate at the time of entry. HealthInvestor Asia will not be held responsible for the publication of any information contained on the entry forms which is inaccurate.

The awards will follow a nomination process where companies will be nominated by the public or self-submission in each relevant category.  Please provide a comprehensive reason for your nomination.

Nominations  must be completed by the closing date of 18 January 2018 

Judging the HealthInvestor Asia Awards is an honour. Judges are chosen for their reputation and independence. Typical profiles of judge include association leaders, think tank leaders, analysts and consultants, independent investors, and (often retired) industry leaders and ambassadors. HealthInvestor Asia diligently to anticipate any conflicts of interest, which judges are expected to declare when categories are allocated.

Once applications are closed, the HealthInvestor Asia editorial team will vet entries and remove any that have not met the basic stipulated requirements.

Entry form



  • Give a short overview of the business, individual or team and its role.
  • Describe its activities during 2018-19 including, where applicable, a full list of education deals on which it worked.
  • Show how your team demonstrated innovation and excellence in working on a specific deal/number of deals or in providing health products and services.

Entry text (Copy/paste)

* If you need to include images, graphs or additional information with your submission please email this to marketing@investorpublishing.co.uk including your company name. You still need to complete this online form.

IMPORTANT - DATA PROTECTION: We may wish to send you information about other products and services in which we think you may be interested or pass on your details to other bona-fide health organisations for mailing purposes.

HealthInvestor Asia Awards 2019

14 May 2019

Singapore

The 2019 awards:

  • Consultancy of the year
  • Law firm of the year
  • Corporate finance team of the year
  • Investor of the year
  • Primary care deal of the year
  • Acute/Secondary care deal of the year
  • Multi-site operator deal of the year
  • Diagnostics deal of the year
  • Health infrastructure/Property deal of the year
  • Grand prix – deal team of the year
“We were thrilled to be named Advisory Firm of the Year at the HealthInvestor Asia Awards in 2018, in recognition of the quality and breadth of the corporate advice and deal support provided to our clients in the healthcare sector across ASEAN.”
Tom Platts
Partner, Stephenson Harwood (Winner: Advisory firm of the year)

About HealthInvestor Asia

HealthInvestor Asia (HIA) is the definitive source of financial intelligence for Apac’s growing healthcare markets. 

HIA’s dedicated coverage of corporate and capital market activity in the healthcare sector provides independent and authoritative insight for investors, lenders, advisors and healthcare firms operating across the region. 

By focusing specifically on the health sector, HIA provides forensic analysis of this vital and growing market. 

HIA’s market-leading editorial coverage enables readers to grasp the complexities of the region and follow the flow of investment across health systems in Asia. Its market commentary and analysis is an invaluable tool in identifying trends and opportunities and its focused reporting allows readers to keep up to date with this fast-moving and exciting sector. 

Contact the team

Sponsorship opportunities:
Paul Routley | +44(0)207 104 2006
Paul.Routley@investorpublishing.co.uk

Marketing opportunities:
Ivan Ujvari | +44(0)207 104 2058
ivan.ujvari@investorpublishing.co.uk